ORPP logo

Pulmonary Hypertension : (Record no. 60840)

MARC details
000 -LEADER
fixed length control field 05385nam a22004573i 4500
001 - CONTROL NUMBER
control field EBC3020361
003 - CONTROL NUMBER IDENTIFIER
control field MiAaPQ
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240729124136.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cnu||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 240724s2012 xx o ||||0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781614706663
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9781614705567
035 ## - SYSTEM CONTROL NUMBER
System control number (MiAaPQ)EBC3020361
035 ## - SYSTEM CONTROL NUMBER
System control number (Au-PeEL)EBL3020361
035 ## - SYSTEM CONTROL NUMBER
System control number (CaPaEBR)ebr10676650
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)829713274
040 ## - CATALOGING SOURCE
Original cataloging agency MiAaPQ
Language of cataloging eng
Description conventions rda
-- pn
Transcribing agency MiAaPQ
Modifying agency MiAaPQ
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RC776.P87 -- P85652 2012eb
082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.2/4
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Gan, Huili.
245 10 - TITLE STATEMENT
Title Pulmonary Hypertension :
Remainder of title Pathogenesis, Diagnosis and Treatments.
250 ## - EDITION STATEMENT
Edition statement 1st ed.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Hauppauge :
Name of producer, publisher, distributor, manufacturer Nova Science Publishers, Incorporated,
Date of production, publication, distribution, manufacture, or copyright notice 2012.
264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice ©2012.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (172 pages)
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
490 1# - SERIES STATEMENT
Series statement Cardiology Research and Clinical Developments
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Intro -- PULMONARY HYPERTENSIONPATHOGENESIS, DIAGNOSIS, AND TREATMENTS -- CARDIOLOGY RESEARCH AND CLINICAL DEVELOPMENTS -- PULMONARY HYPERTENSIONPATHOGENESIS, DIAGNOSIS, AND TREATMENTS -- Library of Congress Cataloging-in-Publication Data -- Contents -- Preface -- Editor's Affiliation -- CHAPTER 1. Pulmonary Hypertension: Pathogenesis, Diagnosis, and Treatments -- Abstract -- Introduction -- Pathogenic Mechanisms -- Cellular Mechanisms -- Smooth Muscle Cells and Fibroblasts -- Endothelial Cells -- Inflammatory Cells -- Platelets and Thrombosis -- Molecular Mechanisms -- Genetic Association -- Acquired/Exogenous Factors -- Vascular Effectors -- Diagnosis -- Screening -- ECG -- Chest X-ray -- Chest CT -- Echocardiography -- Magnetic Resonance Imaging -- Treatments -- General Measures and Supportive Therapy -- Calcium-Channel Blockers -- Anticoagulation -- Prostacyclin Therapy -- Prostacyclin Analogs -- Nitric Oxide -- Phosphodiesterase Type 5 inhibitors -- Endothelin -Receptorantagonists -- Combination Therapy -- Management of PH associated with Congenital Systemic-to-pulmonary Shunts and Eisenmenger's Syndrome -- Novel Speculative Therapies -- Rho-kinase Inhibitor: Fasudil -- PDGF Receptor Antagonist: Imatinib -- Simvastatin -- Ghrelin -- Bradykinin -- Fluoxetine -- Potassium Channel Augmentation -- Apoptosis Signal-Regulating Kinase 1 -- Peroxisome Proliferator-Activated Receptor Gamma -- Elastase Inhibitors -- Survivin -- Conclusion -- References -- CHAPTER 2. Possible Bridging to Final Repair in Eisenmenger Syndrome -- Abstract -- Background -- Pathophysiology of Eisenmenger Syndrome (ES) -- Evaluation of Operability -- Attempts to Increase Operability of ES Patients -- Medical Attempt -- Surgical Attempt -- #ASD -- (1) Shunt Closure with Preceding Targeted Therapies -- (2) Fenestrated ASD Occluder -- #VSD.
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note a. Pop-off Flap and Fenestrated Patch -- b. Pulmonary Artery Banding (PAB) -- #TGA/VSD -- a. Palliative Atrial Switch -- b. Arterial Switch -- Conclusion -- Reference -- CHAPTER 3. The Management of Congenital Systemic-to-Pulmonary Shunt and Advanced Pulmonary Artery Hypertension -- Abstract -- Background -- Methods and results -- Conclusion -- Abbreviations -- Patients and Methods -- Patients -- End Point -- Therapeutic Regimen -- Follow up -- Statistical Analysis -- Results -- The Results from the Whole Cohort of the 1212 Cases of Unmatched Patient -- The Results from the 245 Propensity-Matched Pairs -- The Results of Multivariate Logistic Regression and Cox Proportional Hazard Analysis for the Propensity-matched Patients -- Discussion -- Study Limitation -- References -- CHAPTER 4. Systemic Inflammatory Response Syndrome Associated with Pulmonary Endarterectomy in Patients with Chronic Thromboembolic Pulmonary Hypertension -- Abstract -- Background -- Material and Methods -- Results -- Conclusion -- Abbreviations -- Introduction -- Material and Methods -- Surgical Procedure -- Anesthetic Management -- Hemodynamic Status -- Cytokines, PCT and acute-phase proteins analysis -- Statistical Analysis -- Results -- Conclusion -- Acknowledgment -- References -- CHAPTER 5. Liver Transplantation and Pulmonary Hypertension -- Abstract -- Introduction -- Portopulmonary Hypertension -- Pathophysiology -- Presentation -- Screening -- Pharmacotherapy -- Staging of POPH: Risk Management -- Perioperative Management -- Acute Decompensated Pulmonary Hypertension -- Postoperative Care -- Conclusion -- References -- CHAPTER 6. Pulmonary Hypertension in the Down Syndrome Population -- Abstract -- Introduction -- References -- Index.
588 ## - SOURCE OF DESCRIPTION NOTE
Source of description note Description based on publisher supplied metadata and other sources.
590 ## - LOCAL NOTE (RLIN)
Local note Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pulmonary hypertension.
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Print version:
Main entry heading Gan, Huili
Title Pulmonary Hypertension: Pathogenesis, Diagnosis and Treatments
Place, publisher, and date of publication Hauppauge : Nova Science Publishers, Incorporated,c2012
International Standard Book Number 9781614705567
797 2# - LOCAL ADDED ENTRY--CORPORATE NAME (RLIN)
Corporate name or jurisdiction name as entry element ProQuest (Firm)
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Cardiology Research and Clinical Developments
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3020361">https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3020361</a>
Public note Click to View

No items available.

© 2024 Resource Centre. All rights reserved.